Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Capital City Bank Group
28.1% sales growth and 12.48% return on equity
Capital City Bank Group, Inc. operates as the financial holding company for Capital City Bank that provides a range of banking and banking-related services to individual and corporate clients.
Capital City Bank Group's sales growth this year is expected to be 36.3% and a negative 2.3% for next year.
Year-on-year quarterly revenue growth grew by 49.5%, now sitting on 188.94M for the twelve trailing months.
Capital City Bank Group's sales growth for the next quarter is 28.1%. The company's growth estimates for the current quarter and the next is a negative 2% and 76%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.48%.
Capital City Bank Group's Stock Yearly Top and Bottom Value
Capital City Bank Group's stock is valued at $24.64 at 13:22 EST, way below its 52-week high of $30.95 and way above its 52-week low of $15.61.
Capital City Bank Group's Moving Average
Capital City Bank Group's value is above its 50-day moving average of $23.82 and way above its 200-day moving average of $21.03.2. Goldman Sachs Group, Inc.
14.5% sales growth and 7.31% return on equity
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment management company worldwide.
Goldman Sachs Group, Inc.'s sales growth this year is anticipated to be 15.3% and a negative 9.2% for next year.
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 39.63B for the twelve trailing months.
Goldman Sachs Group, Inc.'s sales growth for the next quarter is 14.5%. The company's growth estimates for the ongoing quarter and the next is 34.8% and 102.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.31%.
Goldman Sachs Group, Inc.'s Stock Yearly Top and Bottom Value
Goldman Sachs Group, Inc.'s stock is valued at $242.13 at 13:22 EST, under its 52-week high of $250.46 and way higher than its 52-week low of $130.85.
Goldman Sachs Group, Inc.'s Moving Average
Goldman Sachs Group, Inc.'s value is above its 50-day moving average of $226.04 and way higher than its 200-day moving average of $209.39.3. Horizon Therapeutics Public Limited Company
34.3% sales growth and 29.59% return on equity
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.
Horizon Therapeutics Public Limited Company's sales growth this year is expected to be 64.1% and 27.3% for next year.
Year-on-year quarterly revenue growth grew by 89.7%, now sitting on 1.82B for the twelve trailing months.
Horizon Therapeutics Public Limited Company's sales growth for the next quarter is 34.3%. The company's growth estimates for the present quarter and the next is 82.1% and 70%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.59%.
Horizon Therapeutics Public Limited Company's Stock Yearly Top and Bottom Value
Horizon Therapeutics Public Limited Company's stock is valued at $68.14 at 13:22 EST, way below its 52-week high of $86.67 and way above its 52-week low of $23.81.
Horizon Therapeutics Public Limited Company's Moving Average
Horizon Therapeutics Public Limited Company's worth is below its 50-day moving average of $72.13 and below its 200-day moving average of $69.08.4. EPAM Systems, Inc.
13.9% sales growth and 18.86% return on equity
EPAM Systems, Inc. provides digital platform engineering and software development services in North America, Europe, Armenia, Belarus, Kazakhstan, Russia, Ukraine, Asia, and Australia.
EPAM Systems, Inc.'s sales growth this year is anticipated to be 15.1% and 21.6% for next year.
Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 2.57B for the twelve trailing months.
EPAM Systems, Inc.'s sales growth for the next quarter is 13.9%. The company's growth estimates for the ongoing quarter and the next is 13.2% and 17.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.86%.
EPAM Systems, Inc.'s Stock Yearly Top and Bottom Value
EPAM Systems, Inc.'s stock is valued at $346.53 at 13:22 EST, under its 52-week high of $359.39 and way above its 52-week low of $151.97.